National and Kapodistrian University of Athens
Οιστρογονικές και νευροπροστατευτικές δράσεις του νευροστεροειδούς δεϋδροεπιανδροστερόνη
Abstract
dc:descriptionThe aim of the study was triple: (1) To determine whether dehydroepiandrosterone (DHEA) exerts hormonal activity in breast cancer cells (MCF-7), in endometrial adenocarcinoma cells (Ishikawa) as well as in prostate adenocarcinoma cells (LNCaP). We were also interested in the type of the receptor which is being involved in mediating DHEA’s activity. The results indicate that DHEA exhibits estrogenic activity in Ishikawa adenocarcinoma cells and in MCF-7 breast cancer cells while it is unable to induce proliferation in LNCaP prostate cells. DHEA activation of MCF-7 cell proliferation was mediated through ERα and required mainly conversion of DHEA to 5-androstenediol (5-diol). Given that 17β hydroxy-steroid-dehydrogenase type 1 (17β HSD-1), the enzyme that converts DHEA to 5-diol, is overexpressed in breast cancer cells, the use of DHEA as a dietary supplement is contraindicated in high risk subjects for breast cancer. (2) To study whether DHEA can modulate the anticancer activity of a chemopreventive factor (ebenfuran III), which is being uptaken by the diet. The results showed that estradiol, at physiological concentrations, was able to improve the anticancer activity of ebenfuran III in breast cancer cells, while DHEA, even at supraphysiological concentrations, was ineffective in this respect. (3) To study whether DHEA and its metabolites can protect the immortalized hippocampal HT22 cells from oxidative stress-induced cell death. The results showed that only E2 is able to protect the HT22 cells, in pharmacological concentrations, while DHEA is ineffective in this respect. We also showed that estradiol, at physiological concentrations, was able through ERα to improve the neuroprotective potency of a synthetic antioxidant (1,4 benzoxazine).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsanou, Efrosini
- Κατσάνου, Ευφροσύνη
Subjects
dc:subject × 20- Δεϋδροεπιανδροστερόνη (DHEA)
- Οιστρογονική δράση
- Καρκίνος μαστού
- Χημειοπροστατευτική δράση
- 17β υδροξυστεροειδο δεϋδρογενάση-1 (17β ΗΣΔ-1)
- Οξειδωτικό στρες
- 5-ανδροστενοδιόλη (5-diol)
- Αρυλβενζοφουράνες
- Dehydroepiandrosrerone (DHEA)
- Estrogenic activity
- Breast cancer
- Chemopreventive activity
- 17β hydroxysteroid dehydrogenase-1 (17β HSD-1)
- 5-androstenediol (5-diol)
- Oxidative stress
- Arylbenzofurans
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14132